JW Pharmaceutical Corporation
Simbolis: 001060.KS
KSC
30750
KRWRinkos kaina šiandien
18.7613
P/E santykis
0.2072
PEG koeficientas
707.11B
MRK kapitalizacija
- 0.01%
DIV pajamingumas
JW Pharmaceutical Corporation (001060-KS) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 369240.03 | 92838 | 149678.7 | 65666.1 | |||||||||||||||||
balance-sheet.row.short-term-investments | 280726.91 | 76929.2 | 115780.8 | 32299.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 689190.07 | 173629.3 | 162146.2 | 192840 | |||||||||||||||||
balance-sheet.row.inventory | 456503.25 | 106091.4 | 111668.4 | 102527.6 | |||||||||||||||||
balance-sheet.row.other-current-assets | 15865.72 | 5532.7 | 1963.7 | 5417.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1530799.07 | 378091.4 | 425457.1 | 366451.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 624681 | 155723.7 | 123048.1 | 118392.3 | |||||||||||||||||
balance-sheet.row.goodwill | 11794.82 | 1404.5 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 96046.76 | 28952 | 16266.2 | 21473.1 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 104378.13 | 30356.4 | 16266.2 | 21473.1 | |||||||||||||||||
balance-sheet.row.long-term-investments | 74489.66 | 52498.2 | -81554 | 69814.7 | |||||||||||||||||
balance-sheet.row.tax-assets | 89655.86 | 20623.3 | 21811.3 | 20802.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 207068.03 | 7745.9 | 122944.1 | 36119.4 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 1100272.68 | 266947.4 | 202515.7 | 266601.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 2631071.75 | 645038.8 | 627972.8 | 633053.1 | |||||||||||||||||
balance-sheet.row.account-payables | 262951.71 | 73847.2 | 82907.9 | 51642.9 | |||||||||||||||||
balance-sheet.row.short-term-debt | 667547.61 | 117404.6 | 207693 | 123074.6 | |||||||||||||||||
balance-sheet.row.tax-payables | 52523.03 | 11113.5 | 13983.9 | 29008.6 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 173876.69 | 30000 | 1849.3 | 122070.1 | |||||||||||||||||
Deferred Revenue Non Current | 1431.95 | 1325.4 | 0 | -13199.8 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 5294.44 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 298716.84 | 89585.4 | 82814.9 | 35045.6 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 309778.22 | 92671.2 | 22082.6 | 161836 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 107834.96 | 22875.8 | 3102.6 | 2600.9 | |||||||||||||||||
balance-sheet.row.total-liab | 1624750.34 | 379598.3 | 402213.7 | 444513.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 14694.66 | 3173.6 | 3973 | 3352.6 | |||||||||||||||||
balance-sheet.row.common-stock | 229703.46 | 57925.9 | 55445.2 | 53849.8 | |||||||||||||||||
balance-sheet.row.retained-earnings | 370663.26 | 92612 | 89129.8 | 58594.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 82131.39 | 53896.2 | 51771.8 | 52070.7 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 323844.34 | 57832.7 | 40034.3 | 33327 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1021037.11 | 265440.5 | 240354.1 | 201194.8 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 2631071.75 | 645038.8 | 627972.8 | 633053.1 | |||||||||||||||||
balance-sheet.row.minority-interest | -14715.71 | 0 | -14595.1 | -12655.2 | |||||||||||||||||
balance-sheet.row.total-equity | 1006321.4 | 265440.5 | 225759 | 188539.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 2631071.75 | - | - | - | |||||||||||||||||
Total Investments | 355216.57 | 129427.3 | 34226.8 | 102114.3 | |||||||||||||||||
balance-sheet.row.total-debt | 887720.78 | 170280.4 | 209542.3 | 245144.7 | |||||||||||||||||
balance-sheet.row.net-debt | 799207.66 | 154371.6 | 175644.4 | 211778.2 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 37151.21 | 35096 | 29852.6 | -1441.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 22574.6 | 22444.6 | 16836.3 | 16111.7 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -20262.51 | -20262.5 | -6169.7 | -46055.8 | |||||||||||||||||
cash-flows.row.account-receivables | -3162.23 | -3162.2 | -4352.5 | -41296.6 | |||||||||||||||||
cash-flows.row.inventory | 8916.8 | 8916.8 | -11541.3 | -2655.1 | |||||||||||||||||
cash-flows.row.account-payables | -9535.56 | -9535.6 | 31652.3 | 3729.7 | |||||||||||||||||
cash-flows.row.other-working-capital | -16481.52 | -16481.5 | -21928.1 | -5833.7 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 47693.94 | 49879.1 | 16245.2 | 49509.5 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 87157.24 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -38561.91 | -42967.2 | -12352.5 | -12901.6 | |||||||||||||||||
cash-flows.row.acquisitions-net | -14325.59 | -12034 | -40.9 | 385 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -61344 | -61344 | -73817.4 | -140023.5 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 69604.03 | 69604 | 47473.7 | 141101.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | -19152.8 | -17093.1 | 19817.9 | -11430.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -63780.27 | -63834.3 | -18919.2 | -22869.2 | |||||||||||||||||
cash-flows.row.debt-repayment | -216351.12 | -28189.8 | -177004.4 | -98658.1 | |||||||||||||||||
cash-flows.row.common-stock-issued | 7880.94 | -3873 | 10000 | 398.5 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -260.87 | -260.9 | -281.6 | -412.3 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -8813.7 | -7352 | -7149.5 | |||||||||||||||||
cash-flows.row.other-financing-activites | 176299.39 | -54 | 137730.5 | 133023 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -41245.33 | -41191.3 | -36907.5 | 27201.6 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -120.69 | -120.7 | -406.4 | 458.7 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -17989.06 | -17989.1 | 531.4 | 22915.1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 88513.13 | 15908.9 | 33897.9 | 33366.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 106502.18 | 33897.9 | 33366.5 | 10451.3 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 87157.24 | 87157.2 | 56764.4 | 18124 | |||||||||||||||||
cash-flows.row.capital-expenditure | -38561.91 | -42967.2 | -12352.5 | -12901.6 | |||||||||||||||||
cash-flows.row.free-cash-flow | 48595.33 | 44190 | 44411.9 | 5222.4 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 748526.71 | 748526.7 | 684351.1 | 606584.9 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 412984.31 | 412854.3 | 396396.6 | 372208.6 | |||||||||||||||||
income-statement-row.row.gross-profit | 335542.4 | 335672.4 | 287954.5 | 234376.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 33671.36 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 204703.62 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 35443.42 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -253431.49 | -36136.8 | 64701.4 | 67954.7 | |||||||||||||||||
income-statement-row.row.operating-expenses | -2317.17 | 238911.4 | 225175.5 | 203176.5 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 474255.45 | 651765.7 | 621572 | 575385.1 | |||||||||||||||||
income-statement-row.row.interest-income | 5893.15 | 5893.1 | 5321.5 | 1654.8 | |||||||||||||||||
income-statement-row.row.interest-expense | 9617.04 | 12561.7 | 9386.8 | 7336.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 35443.42 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -45650.78 | -42545.6 | -17598.9 | -10667.2 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -253431.49 | -36136.8 | 64701.4 | 67954.7 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -45650.78 | -42545.6 | -17598.9 | -10667.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 9617.04 | 12561.7 | 9386.8 | 7336.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 179363.79 | 22444.6 | 19571.5 | 16180.7 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 279325.21 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 99961.42 | 96761 | 62960.9 | 31199.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 54310.64 | 54215.4 | 45362 | 20532.7 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 16406.19 | 16406.2 | 15509.4 | 21974.1 | |||||||||||||||||
income-statement-row.row.net-income | 37006.33 | 37006.3 | 31891.7 | -1441.5 |
Dažnai užduodami klausimai
Kas yra JW Pharmaceutical Corporation (001060.KS) bendras turtas?
JW Pharmaceutical Corporation (001060.KS) bendras turtas yra 645038796101.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 389220837356.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.448.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 2124.292.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.049.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.134.
Kas yra JW Pharmaceutical Corporation (001060.KS) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 37006333990.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 170280439662.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 238911370958.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 15908868301.000.